TREA

79338223 - NYKODE THERAPEUTICS

Follow

Information

  • Trademark
  • 79338223
  • Serial Number
    79338223
  • Registration Number
    7203865
  • Filing Date
    November 29, 2021
    3 years ago
  • Registration Date
    October 31, 2023
    a year ago
  • Transaction Date
    February 26, 2024
    a year ago
  • Status Date
    October 31, 2023
    a year ago
  • Published for Opposition Date
    August 15, 2023
    a year ago
  • Location Date
    October 31, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    DIBLE, JONATHON I
  • Attorney Docket Number
    T37805USIP
    Attorney Name
    Christian D. Abel
    Law Office Assigned Location Code
    M20
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
NYKODE THERAPEUTICS
Case File Statements
  • GS0401: Treatment of biological materials for use in production of pharmaceutical preparations by means of culturing, expansion, filtration, purification, addition of pharmaceutical excipients and carriers, as well as the portioning and packing of those materials; processing and custom manufacturing of pharmaceuticals for others; processing and custom manufacturing of preparations for cancer treatment, preparations for treatment of tumors, immunotherapeutic preparations, anti-cancer preparations for injection, radioactive preparations for radiation treatment, radioactive pharmaceuticals, vaccines, preparations for treatment of viral diseases, preparations for treatment of allergies, preparations for treatment of autoimmune diseases, immunostimulants, biological preparations for treatment of cancer, biological preparations for treatment of viral diseases, biological preparations for treatment of allergies, biological preparations for treatment of autoimmune diseases and medical diagnostic preparations for others
  • GS0091: Laboratory instruments and apparatus for analyzing nucleic acids, DNA, RNA, peptides, proteins, lipids, polysaccharides, antigens and antigen presenting cells, for preparation, filtration and separation of nucleic acids, DNA, RNA, peptides, proteins, lipids, poly saccharides, antigens and antigen presenting cells, and for chromatography, not for medical purposes; Downloadable medical software and mobile application for use with immunotherapy, namely, compiling medical data, analyzing test results, and evaluating medical data; Downloadable medical software for designing pharmaceuticals; Downloadable medical software and mobile applications allowing user selection of antigens for designing personalized medicines; Downloadable medical software and mobile applications for user selection of antigens for designing pharmaceuticals
  • GS0051: Pharmaceuticals and veterinary preparations for treatment of immune diseases, cancer, tumors, infectious diseases and viral diseases; sanitary preparations for medical purposes; dietary supplements for humans and animals; Immunotherapeutic preparations, namely vaccines against immune diseases, cancer, tumors, infectious diseases and viral diseases; Pharmaceutical preparations for the treatments of cancer; Pharmaceutical preparations for treatment of tumors; anti-cancer pharmaceutical preparations for injections; Radioactive pharmaceutical preparations for radiation treatment; Radioactive substances for medical purposes; Diagnostic preparations for medical and veterinary purposes; pharmaceutical preparations for treatment of infectious diseases; pharmaceutical preparations for treatment of viral diseases; Immunotherapeutic preparations, namely vaccines against immune diseases, cancer, tumors, infectious diseases and viral diseases; biological preparations for treatment of cancer; biological preparations for treatment of infectious diseases; biological preparations for treatment of viral diseases; vaccines; immunostimulants; pharmaceutical preparations for treatment of allergies; biological preparations for treatment of allergies; pharmaceutical preparations for treatment of autoimmune diseases; biological preparations for treatment of autoimmune diseases
  • GS0351: Promoting the goods of others, namely, pharmaceutical products, biological preparations, medical diagnostic products, vaccines, anti-cancer pharmaceutical products, and immunotherapeutic pharmaceuticals and products; retail store services featuring pharmaceutical products, biological preparations, medical diagnostic products, vaccines, anti-cancer pharmaceutical products, and immunotherapeutic pharmaceuticals and products
  • GS0441: Providing information in the field of medicine and health in related to the treatment of tumors, immunotherapeutic preparations, anti-cancer preparations for injection, radioactive preparations for radiation treatment, radioactive pharmaceuticals, vaccines, preparations for treatment of viral diseases, preparations for treatment of allergies, preparations for treatment of autoimmune diseases, immunostimulants, biological preparations for treatment of cancer, biological preparations for treatment of viral diseases, biological preparations for treatment of allergies, biological preparations for treatment of autoimmune diseases and diagnostic preparations; medical and pharmaceutical consulting services in the field of treatment of tumors, immunotherapeutic preparations, anti-cancer preparations for injection, radioactive preparations for radiation treatment, radioactive pharmaceuticals, vaccines, preparations for treatment of viral diseases, preparations for treatment of allergies, preparations for treatment of autoimmune diseases, immunostimulants, biological preparations for treatment of cancer, biological preparations for treatment of viral diseases, biological preparations for treatment of allergies, biological preparations for treatment of autoimmune diseases and diagnostic preparations; Provision of medical services by health care professions, namely, hygiene care for human beings in the field of treatment of tumors, immunotherapeutic preparations, anti-cancer preparations for injection, radioactive preparations for radiation treatment, radioactive pharmaceuticals, vaccines, preparations for treatment of viral diseases, preparations for treatment of allergies, preparations for treatment of autoimmune diseases, immunostimulants, biological preparations for treatment of cancer, biological preparations for treatment of viral diseases, biological preparations for treatment of allergies, biological preparations for treatment of autoimmune diseases and diagnostic preparations; medical clinic services
  • D10000: "THERAPEUTICS"
  • GS0421: Scientific and technological laboratory services and research and design relating thereto, all in the field of pharmaceuticals and vaccines; Industrial analysis and research services in the field of pharmaceuticals and vaccines; design and development of computer hardware and software; design, research and development of pharmaceuticals, preparations for cancer treatment, preparations for treatment of tumors, immunotherapeutic preparations, anti-cancer preparations for injection, radioactive preparations for radiation treatment, radioactive pharmaceuticals, vaccines, preparations for treatment of viral diseases, preparations for treatment of allergies, preparations for treatment of autoimmune diseases, immunostimulants, biological preparations for treatment of cancer, biological preparations for treatment of viral diseases, biological preparations for treatment of allergies, biological preparations for treatment of autoimmune diseases and medical diagnostic preparations; design and development of medical diagnostic equipment and medical instruments; research and development in the field of medical diagnostic preparations; design and development of medical techniques; Pharmaceutical research and development; Scientific and technological consultancy related to the aforesaid services
Case File Event Statements
  • 2/26/2024 - a year ago
    52 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 2/1/2024 - a year ago
    51 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 2/1/2024 - a year ago
    50 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 1/31/2024 - a year ago
    49 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 10/31/2023 - a year ago
    48 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 10/31/2023 - a year ago
    47 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/9/2023 - a year ago
    46 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 9/20/2023 - a year ago
    45 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 9/20/2023 - a year ago
    44 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 8/15/2023 - a year ago
    43 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/15/2023 - a year ago
    42 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/14/2023 - a year ago
    41 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 7/26/2023 - a year ago
    40 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 7/26/2023 - a year ago
    39 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 7/26/2023 - a year ago
    38 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/11/2023 - a year ago
    37 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/11/2023 - a year ago
    36 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/5/2023 - a year ago
    35 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 7/5/2023 - a year ago
    34 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 7/5/2023 - a year ago
    33 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 7/5/2023 - a year ago
    32 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/26/2023 - 2 years ago
    31 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/26/2023 - 2 years ago
    30 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/26/2023 - 2 years ago
    29 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/26/2023 - 2 years ago
    28 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/23/2023 - 2 years ago
    27 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/23/2023 - 2 years ago
    26 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/23/2023 - 2 years ago
    25 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/23/2023 - 2 years ago
    24 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/22/2023 - 2 years ago
    23 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/22/2023 - 2 years ago
    22 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/22/2023 - 2 years ago
    21 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/22/2023 - 2 years ago
    20 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/12/2023 - 2 years ago
    19 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/12/2023 - 2 years ago
    18 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/12/2023 - 2 years ago
    17 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/12/2023 - 2 years ago
    16 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 5/22/2023 - 2 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/22/2023 - 2 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/22/2023 - 2 years ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/4/2023 - 2 years ago
    12 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 12/22/2022 - 2 years ago
    11 - REFUSAL PROCESSED BY IB Type: RFNT
  • 11/26/2022 - 2 years ago
    10 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 11/26/2022 - 2 years ago
    9 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 9/20/2022 - 2 years ago
    8 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 9/19/2022 - 2 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/8/2022 - 2 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/30/2022 - 2 years ago
    5 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 5/8/2022 - 3 years ago
    4 - CHANGE OF OWNER RECEIVED FROM IB Type: CHLD
  • 4/22/2022 - 3 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 4/18/2022 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/14/2022 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR